Canadian, Israeli Cannabis Cos. Terminate $35M Merger Deal
An acquisition agreement between Canadian cannabis company InterCure Ltd. and Israeli medical cannabis operator Cann Pharmaceutical Ltd. automatically terminated Tuesday due to disagreements between the parties and the deal's failure to...To view the full article, register now.
Already a subscriber? Click here to view full article